These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

188 related articles for article (PubMed ID: 35075772)

  • 21. CpG island methylator phenotype predicts progression of malignant melanoma.
    Tanemura A; Terando AM; Sim MS; van Hoesel AQ; de Maat MF; Morton DL; Hoon DS
    Clin Cancer Res; 2009 Mar; 15(5):1801-7. PubMed ID: 19223509
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Melanoma transition is frequently accompanied by a loss of cytoglobin expression in melanocytes: a novel expression site of cytoglobin.
    Fujita Y; Koinuma S; De Velasco MA; Bolz J; Togashi Y; Terashima M; Hayashi H; Matsuo T; Nishio K
    PLoS One; 2014; 9(4):e94772. PubMed ID: 24722418
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Oxidative stress modulates DNA methylation during melanocyte anchorage blockade associated with malignant transformation.
    Campos AC; Molognoni F; Melo FH; Galdieri LC; Carneiro CR; D'Almeida V; Correa M; Jasiulionis MG
    Neoplasia; 2007 Dec; 9(12):1111-21. PubMed ID: 18084618
    [TBL] [Abstract][Full Text] [Related]  

  • 24. CDKN2B Loss Promotes Progression from Benign Melanocytic Nevus to Melanoma.
    McNeal AS; Liu K; Nakhate V; Natale CA; Duperret EK; Capell BC; Dentchev T; Berger SL; Herlyn M; Seykora JT; Ridky TW
    Cancer Discov; 2015 Oct; 5(10):1072-85. PubMed ID: 26183406
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Epigenetic silencing of TET2 and TET3 induces an EMT-like process in melanoma.
    Gong F; Guo Y; Niu Y; Jin J; Zhang X; Shi X; Zhang L; Li R; Chen L; Ma RZ
    Oncotarget; 2017 Jan; 8(1):315-328. PubMed ID: 27852070
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Comprehensive analysis of tumor necrosis factor receptor TNFRSF9 (4-1BB) DNA methylation with regard to molecular and clinicopathological features, immune infiltrates, and response prediction to immunotherapy in melanoma.
    Fröhlich A; Loick S; Bawden EG; Fietz S; Dietrich J; Diekmann E; Saavedra G; Fröhlich H; Niebel D; Sirokay J; Zarbl R; Gielen GH; Kristiansen G; Bootz F; Landsberg J; Dietrich D
    EBioMedicine; 2020 Feb; 52():102647. PubMed ID: 32028068
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Genome-wide promoter methylation analysis identifies epigenetic silencing of MAPK13 in primary cutaneous melanoma.
    Gao L; Smit MA; van den Oord JJ; Goeman JJ; Verdegaal EM; van der Burg SH; Stas M; Beck S; Gruis NA; Tensen CP; Willemze R; Peeper DS; van Doorn R
    Pigment Cell Melanoma Res; 2013 Jul; 26(4):542-54. PubMed ID: 23590314
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Integrated differential DNA methylation and gene expression of formalin-fixed paraffin-embedded uveal melanoma specimens identifies genes associated with early metastasis and poor prognosis.
    Ness C; Katta K; Garred Ø; Kumar T; Olstad OK; Petrovski G; Moe MC; Noer A
    Exp Eye Res; 2021 Feb; 203():108426. PubMed ID: 33387485
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Network assessment of demethylation treatment in melanoma: Differential transcriptome-methylome and antigen profile signatures.
    Jiang Z; Cinti C; Taranta M; Mattioli E; Schena E; Singh S; Khurana R; Lattanzi G; Tsinoremas NF; Capobianco E
    PLoS One; 2018; 13(11):e0206686. PubMed ID: 30485296
    [TBL] [Abstract][Full Text] [Related]  

  • 30. In-depth genomic data analyses revealed complex transcriptional and epigenetic dysregulations of BRAFV600E in melanoma.
    Guo X; Xu Y; Zhao Z
    Mol Cancer; 2015 Mar; 14():60. PubMed ID: 25890285
    [TBL] [Abstract][Full Text] [Related]  

  • 31. The melanocyte differentiation program predisposes to metastasis after neoplastic transformation.
    Gupta PB; Kuperwasser C; Brunet JP; Ramaswamy S; Kuo WL; Gray JW; Naber SP; Weinberg RA
    Nat Genet; 2005 Oct; 37(10):1047-54. PubMed ID: 16142232
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Gene expression and promoter methylation of angiogenic and lymphangiogenic factors as prognostic markers in melanoma.
    Monteiro AC; Muenzner JK; Andrade F; Rius FE; Ostalecki C; Geppert CI; Agaimy A; Hartmann A; Fujita A; Schneider-Stock R; Jasiulionis MG
    Mol Oncol; 2019 Jun; 13(6):1433-1449. PubMed ID: 31069961
    [TBL] [Abstract][Full Text] [Related]  

  • 33. The DNA methylation profile of liver tumors in C3H mice and identification of differentially methylated regions involved in the regulation of tumorigenic genes.
    Matsushita J; Okamura K; Nakabayashi K; Suzuki T; Horibe Y; Kawai T; Sakurai T; Yamashita S; Higami Y; Ichihara G; Hata K; Nohara K
    BMC Cancer; 2018 Mar; 18(1):317. PubMed ID: 29566670
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Identification of novel epigenetically modified genes in human melanoma via promoter methylation gene profiling.
    Liu S; Ren S; Howell P; Fodstad O; Riker AI
    Pigment Cell Melanoma Res; 2008 Oct; 21(5):545-58. PubMed ID: 18627528
    [TBL] [Abstract][Full Text] [Related]  

  • 35. The DNA methylation landscape of human melanoma.
    Jin SG; Xiong W; Wu X; Yang L; Pfeifer GP
    Genomics; 2015 Dec; 106(6):322-30. PubMed ID: 26384656
    [TBL] [Abstract][Full Text] [Related]  

  • 36. ALDH1A3 is epigenetically regulated during melanocyte transformation and is a target for melanoma treatment.
    Pérez-Alea M; McGrail K; Sánchez-Redondo S; Ferrer B; Fournet G; Cortés J; Muñoz E; Hernandez-Losa J; Tenbaum S; Martin G; Costello R; Ceylan I; Garcia-Patos V; Recio JA
    Oncogene; 2017 Oct; 36(41):5695-5708. PubMed ID: 28581514
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Comprehensive DNA methylation study identifies novel progression-related and prognostic markers for cutaneous melanoma.
    Wouters J; Vizoso M; Martinez-Cardus A; Carmona FJ; Govaere O; Laguna T; Joseph J; Dynoodt P; Aura C; Foth M; Cloots R; van den Hurk K; Balint B; Murphy IG; McDermott EW; Sheahan K; Jirström K; Nodin B; Mallya-Udupi G; van den Oord JJ; Gallagher WM; Esteller M
    BMC Med; 2017 Jun; 15(1):101. PubMed ID: 28578692
    [TBL] [Abstract][Full Text] [Related]  

  • 38. The AP-1 transcription factor FOSL1 causes melanocyte reprogramming and transformation.
    Maurus K; Hufnagel A; Geiger F; Graf S; Berking C; Heinemann A; Paschen A; Kneitz S; Stigloher C; Geissinger E; Otto C; Bosserhoff A; Schartl M; Meierjohann S
    Oncogene; 2017 Sep; 36(36):5110-5121. PubMed ID: 28481878
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Genetic and epigenetic alterations of the APC gene in malignant melanoma.
    Worm J; Christensen C; Grønbaek K; Tulchinsky E; Guldberg P
    Oncogene; 2004 Jul; 23(30):5215-26. PubMed ID: 15133491
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Identification and analysis of an early diagnostic marker for malignant melanoma: ZAR1 intra-genic differential methylation.
    Shinojima Y; Terui T; Hara H; Kimura M; Igarashi J; Wang X; Kawashima H; Kobayashi Y; Muroi S; Hayakawa S; Esumi M; Fujiwara K; Ghosh S; Yamamoto T; Held W; Nagase H
    J Dermatol Sci; 2010 Aug; 59(2):98-106. PubMed ID: 20654783
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 10.